Stipulation of Non-Infringement Found Insufficient for Appeal
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by: Justin J. Gillett & Kenneth O. Aruda, Ph.D.
ALTERWAN, INC. V. AMAZON.COM, INC., AMAZON WEB SERVICES, INC.
Before Lourie, Dyk, and Stoll. Appeal from the United States District Court for the District of Delaware.
Summary: The Federal Circuit declined to reach the merits of a claim-construction appeal after finding the parties’ stipulation of non-infringement did not provide sufficient detail.
AlterWAN sued Amazon alleging infringement of patent claims relating to implementing wide area networks. The district court construed two claim terms at issue on appeal. Thereafter, the parties filed a stipulation that Amazon does not infringe under those constructions. The district court entered final judgment and AlterWAN appealed the district court’s claim construction.
The Federal Circuit held that the stipulation of non-infringement did not provide sufficient detail to allow the Court to resolve the claim construction issues presented on appeal. The Court found it unclear whether, under the stipulation, Amazon prevails on infringement if the construction of either disputed term is correct or only if both are correct. Accordingly, the Federal Circuit vacated the judgment and remanded to clarify the parties’ non-infringement positions, and to determine whether a stipulation of non-infringement is possible in the case.
Editor: Paul Stewart
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…